Clinical trial · Observational
oncoFISH Cervical Test for Detection of 3q26 Region Gain
The oncoFISH Cervical Test for Detection of 3q26 Region Gain
NCT01416922CI-TRIAL-00005365unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the use of the oncoFISH cervical test system in the management of women who have received an LSIL Pap report to determine whether the test can predict which women will progress to more serious cervical disease and which women do not have to be monitored as closely.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
| LSIL | Low Grade Squamous Intraepithelial Neoplasia | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- LSIL
- description
- Women 21 years of age or older with an LSIL diagnosis
Primary outcomes (0)
[]Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * Women 21 years of age or greater with recent LSIL who are scheduled for colposcipal assessment. * Women with previous or current STD or HIV may be included * Women with previous LSIL history may be included. Exclusion Criteria: * pregnant women, * women with vaginal intraepithelial lesions, * women on a chemotherapeutic agent, * women with previous or current cancer except for non-cervical squamous cell carcinoma
References
Publications (0)
Data not yet available
No reference posted for this study.